ICV aggregates private and institutional donated capital for a diverse range of projects that can create systemic and sustainable change. We use all possible tools and donor resources available to solve the most pressing problems that no one nonprofit can solve alone.
An Innovative Approach to Philanthropy
ICV takes an investment approach to philanthropy, conducting extensive due diligence on early and mid-stage nonprofit organizations for selection within a well-diversified portfolio. We also work closely with the top centers of innovation, identifying breakthrough technologies developed by the top researchers around the world.
We offer innovative financing solutions for impact-oriented philanthropists who wish to allocate tax-deductible, donated capital. Through donor-advised funds, for example, philanthropists can make an up-front donation and receive a tax-deduction in the year they make the donation. Funds are allocated by project and managed to potentially grow, tax-free.
We provide transparency, impact reporting and legacy planning support to give philanthropists the confidence that their confidence is creating maximum impact.
ICV Catalytic Philanthropy is led by a team of investment professionals who bring decades of experience in the areas of sourcing, analyzing, structuring, and financing impactful, mission-driven businesses.
- Allocate capital on behalf of family offices
- Serve on the boards of private, grant-making foundations
- Manage large pools of institutional capital
- Lead corporate boards towards performance and efficiency, stewarding strategic planning and risk management
- Deep analytical experience to assess social impact and measurement of outcomes
“Plenty of billionaires are still buying sports teams, building yachts and donating to museums and hospitals. But many new philanthropists appear less interested in naming a business school after themselves than in changing the world.”
– The New York Times, October 20, 2017
ICV’s catalytic projects are led by people who have the character, courage and commitment to solving the world’s greatest challenges. Our teams conduct essential on-the-ground research, including large-scale interviews, to clarify risks and evaluate financing needs. We leverage local specificities of the place, people and culture for the most efficient and sustainable outcomes. ICV participates in coalitions and forms public-private partnerships to leverage the resources of some of the biggest names in development.
The Cancer Breakthroughs Fund, a partnership between ICV and Jefferson, was created to invest in proof-of-concept studies that typically go unfunded through traditional government and industry sources, fuel early-stage investigators in cancer research, and support the next generation of cancer researchers and clinicians who hope to write the final chapters of the story that puts cancer into the history books. We are proud to work with Dr. Karen Knudsen, Director of the Sidney Kimmel Cancer Center and Association of American Cancer Institutes’ President-Elect, who is one of the top researchers of prostate cancer in the world.
The Cancer Breakthroughs Fund can also allocate to the ICV Cancer Impact Grants to fuel the research of HDFCCC’s most promising and innovative physician-scientists. Each quarter, Alan Ashworth, PhD, FRS – President, UCSF Helen Diller Family Comprehensive Cancer Center and E. Dixon Heise Distinguished Professor in Oncology— and the HDFCCC review panel, will select one Impact Grant winner. All ICV members will be kept abreast of the latest findings and breakthroughs made possible by the Fund and the projects of the grant recipients.
The Every Breath Counts Fund is a private-public partnership of some of the biggest names in development that formed the Every Breath Counts Coalition, where ICV shall bring visibility to the burden of pneumonia, the leading killer of children under 5. ICV is working closely with the Clinton Health Access Initiative to serve the most vulnerable population, Nigeria, by catalyzing investment in innovations and breakthrough technologies.
The Give Freedom Fund is designed for wealthy individuals who wish to advance the well-being of humankind but who may not have the time to diligence organizations or who consider their allocations too large for the capacity of early-stage organizations. ICV has carefully selected early and mid-stage nonprofit organizations — focused on ending modern slavery, human trafficking with an emphasis on sex trafficking, and violence against women and children — for a portfolio structured within a donor-advised fund. ICV conducts extensive due diligence on the organizations, gaining transparency which we, in turn, provide to our donors along with measurable results.
The Inner and Outer Peace Fund is designed to advance human potential and effect positive change for humankind. Through Educate Hearts and Minds, we will create synergistic programs between the west and the east to foster benevolent human beings. The initial focus of the Fund will be to allocate capital to educational organizations in low-income communities.
In our overly stimulated and chaotic world, A Modern Day Sacred Space helps us find authentic presence in a culture of busyness. This groundbreaking and iconographic meditation orb reinvents the concept of sacred space, with purposefully built installations that reduce stress and restore mind body balance. We will host Spiritual Retreats for investors, philanthropists, entreprenuers and change makers in comfortable and inspirational settings: To do good outside, we must go inside.
New Era World Model will build economically empowered, socially responsible and environmentally sustainable communities while maintaining their cultural dignity and natural identity. The NEW model engages community leaders and works from the bottom up, then to the top down to create a sustainable system that the community wants.
The Next Pandemic Fund will initially invest in research focused on antimicrobial resistance (AMR), Methicillin-resistant Staphylococcus aureus (MRSA), and influenza. The Fund will serve as a vital source of support for innovative research being conducted at Stanford Medicine and Washington University in St. Louis School of Medicine.
“It’s immoral to be discouraged by the magnitude of a problem. The good that we can do, we must do.”
– Mother Teresa
The Omnis Fund, a partnership between ICV and the Omnis Institute, was created to support critical research focused on solutions to the health disparities in both refugee camps and urban refugee communities.
Preventing Nuclear War Fund supports two campaigns to help global citizens understand the enormity of worldwide climate disruption caused by a limited, regional nuclear war and to shift nuclear weapons budgets and investments to better purposes. Back from the Brink will employ a strategy to help global citizens understand the enormity of worldwide climate disruption caused by a limited, regional nuclear war; the great and increasing danger that nuclear weapons will be used; and, the reality that nuclear weapons are the greatest threat to our health, safety, and security. Move the Nuclear Weapons Money will employ a strategy to shift nuclear weapons budgets and investments to better purposes, such as economic development, ending poverty, protecting the climate, supporting renewable energy, creating jobs, and providing adequate healthcare, housing and education for all.
Water is a Human Right will advance the efforts of the Global Interfaith WASH Alliance, the world’s first initiative that is engaging the planet’s many faiths as allies in efforts to create a world where every human being has access to safe drinking water, improved sanitation and proper hygiene.
Philanthropy: Love of Humankind
At the end of the day, at the end of our lives, we will ask ourselves whether we could have done more for the health and well-being of the planet, of humanity and all living things. We invite you to join us as a new kind of philanthropist, to leverage your charitable giving to create systemic change.
As a tax-exempt public charity as defined by the Internal Revenue Code (IRC) Sections 501(c)(3). ICV Group, Inc. is eligible to receive tax-deductible charitable contributions under IRC Section 170 and is qualified to receive tax deductible bequests, devises, transfers or gifts under Section 2055, 2106 or 2522 (EIN: 82-2698363).
“Carry on a mission to bring smiles and tender thoughts to the great in heart in high and low places, to comfort and cheer those who do exceptional things or suffer.”
– William E. Harmon